KATIE HYATT: Open Payments
NPI 1194385823 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$751 in 46 payments from 16 companies in 2025. Trend: 2023 $1,172 · 2024 $1,040 · 2025 $751
Food & beverage: $751
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $164 |
| ABBVIE INC. | 4 | $88 |
| Otsuka America Pharmaceutical, Inc. | 3 | $75 |
| Esperion Therapeutics, Inc. | 4 | $71 |
| Exact Sciences Corporation | 3 | $53 |
| SANOFI-AVENTIS U.S. LLC | 2 | $47 |
| Lilly USA, LLC | 3 | $43 |
| GlaxoSmithKline, LLC. | 2 | $40 |
| Radius Health, Inc. | 2 | $35 |
| Madrigal Pharmaceuticals | 1 | $31 |
Products named: Wegovy, Ozempic, REXULTI, NEXLETOL, QULIPTA, Cologuard Collection Kit, TZIELD, TRELEGY ELLIPTA.
Industry payments across NC — which companies pay providers there.
